Physician

Wallace Austin Smith, M.D.

According to 2025 Medicare claims, Wallace Smith, M.D. (NPI: 1376800532) practices dermatology in the St. George, UT market, with the plurality of this provider's patient population coming from Washington, UT. This provider's primary affiliated billing organization is SOUTHWEST SKIN AND CANCER LLC (NPI: 1619929783; TIN: 20-4240264) and primary practice location at 84770-3620.

Smith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,305 traditional Medicare patients, billed 16,078 HCPCS/CPT codes, and received $725,213 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 523 prescription claims across 311 beneficiaries totaling $147,651 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 40 records totaling $683. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $136,885 to $725,213. Similarly, Part D prescription costs have risen steadily, from $22,334 to $147,651. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$363K$725K2016 Medicare payment: $136,885 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $403,945 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $419,431 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $524,192 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $562,593 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $476,509 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $448,904 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $608,296 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $725,213 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20165952,763$136,885
20171,4398,565$403,945
20181,41913,098$419,431
20191,59911,982$524,192
20201,63213,211$562,593
20211,42710,892$476,509
20221,3419,953$448,904
20231,76314,521$608,296
20242,30516,078$725,213

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$183K$367K2015 Drug cost: $22,334 (USD; Tot_Drug_Cst)2016 Drug cost: $21,340 (USD; Tot_Drug_Cst)2017 Drug cost: $91,492 (USD; Tot_Drug_Cst)2018 Drug cost: $65,530 (USD; Tot_Drug_Cst)2019 Drug cost: $79,665 (USD; Tot_Drug_Cst)2020 Drug cost: $256,476 (USD; Tot_Drug_Cst)2021 Drug cost: $349,612 (USD; Tot_Drug_Cst)2022 Drug cost: $311,966 (USD; Tot_Drug_Cst)2023 Drug cost: $366,656 (USD; Tot_Drug_Cst)2024 Drug cost: $147,651 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015124251$22,334
2016177321$21,340
2017367670$91,492
2018458907$65,530
2019445921$79,665
2020446852$256,476
2021383757$349,612
2022352590$311,966
2023353644$366,656
2024311523$147,651

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth661749$61
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,8942,755$54
88305Pathology examination of tissue using a microscope, intermediate complexity573893$49
17000Destruction of precancer skin growth, 1 growth1,3751,852$36
17003Destruction of precancer skin growth, 2-14 growths1,1227,128$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab14392$53,692
Dupixent SyringeDupilumab12336$46,779
Clobetasol PropionateClobetasol Propionate36897$1,515
Triamcinolone AcetonideTriamcinolone Acetonide752,712$1,034
ValacyclovirValacyclovir Hcl12219$969

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.40$683ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Wallace Austin Smith, M.D.?

Tedicare shows public-source Medicare data for Wallace Austin Smith, M.D. (NPI 1376800532), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wallace Austin Smith, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Wallace Austin Smith, M.D.?

Wallace Austin Smith, M.D. is linked to SOUTHWEST SKIN AND CANCER LLC (billing NPI 1619929783) in the available physician profile data.

Does Wallace Austin Smith, M.D. have Open Payments data?

Wallace Austin Smith, M.D. has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.